Two Magnaporthe appressoria‐specific (MAS) proteins,MoMas3 and MoMas5, are required for suppressing host innate immunity and promoting biotrophic growth in rice cells

In the devastating rice blast fungus Magnaporthe oryzae, six Magnaporthe appressoria‐specific (MAS) proteins are encoded by MoGAS1, MoGAS2 and MoMAS3–MoMAS6. MoGAS1 and MoGAS2 were previously characterized as M. oryzae virulence factors; however, the roles of the other four genes are unknown. Here, we found that, although the loss of any MAS gene did not affect appressorial formation or vegetative growth, ∆Momas3 and ∆Momas5 mutant strains (but not the others) were reduced in virulence on susceptible CO‐39 rice seedlings. Focusing on ∆Momas3 and ∆Momas5 mutant strains, we found that they could penetrate host leaf surfaces and fill the first infected rice cell but did not spread readily to neighbouring cells, suggesting they were impaired for biotrophic growth. Live‐cell imaging of fluorescently labelled MoMas3 and MoMas5 proteins showed that during biotrophy, MoMas3 localized to the apoplastic compartment formed between fungal invasive hyphae and the plant‐derived extra‐invasive hyphal membrane while MoMas5 localized to the appressoria and the penetration peg. The loss of either MoMAS3 or MoMAS5 resulted in the accumulation of reactive oxygen species (ROS) in infected rice cells, resulting in the triggering of plant defences that inhibited mutant growth in planta. ∆Momas3 and ∆Momas5 biotrophic growth could be remediated by inhibiting host NADPH oxidases and suppressing ROS accumulation. Thus, MoMas3 and MoMas5 are novel virulence factors involved in suppressing host plant innate immunity to promote biotrophic growth.     

History of gene therapy

Two decades after the initial gene therapy trials and more than 1700 approved clinical trials worldwide we not only have gained much new information and knowledge regarding gene therapy in general, but also learned to understand the concern that has persisted in society. Despite the setbacks gene therapy has faced, success stories have increasingly emerged. Examples for these are the positive recommendation for a gene therapy product (Glybera) by the EMA for approval in the European Union and the positive trials for the treatment of ADA deficiency, SCID-X1 and adrenoleukodystrophy. Nevertheless, our knowledge continues to grow and during the course of time more safety data has become available that helps us to develop better gene therapy approaches. Also, with the increased understanding of molecular medicine, we have been able to develop more specific and efficient gene transfer vectors which are now producing clinical results.     

植物磷酸烯醇式丙酮酸羧化酶的可逆胍变性

纯化的高梁叶片磷酸烯醇式丙酮酸羧化酶(PEP羧化酶)经不同浓度的盐酸胍处理变性失活后,在试验的蛋白浓度范围内,它的失活时间进程的动力学分析表明为一级反应。0.4 M盐酸胍处理25分钟后(O℃),酶的催化活性完全丧失,酶蛋白的远紫外圆二色性光谱、内源荧光光谱及免疫特异性等测定均表明酶的结构发生了深刻变化。甘油及PEP羧化酶的变构效应剂G6P和甘氨酸对酶在盐酸胍溶液中的变性作用有一定的保护效果。变性酶用复性缓冲液稀释20倍后,在最佳条件下,再经30分钟保温,酶的催化活性能恢复70％以上。G6P和甘氨酸能促进变性酶的复性,甘油亦有明显效果。随着酶活性的恢复,它的远紫外圆二色性、内源荧光及免疫特异性也随之恢复,变性酶的复性速率在常温下(25℃)比在低温下(0℃)要快得多。     

Lipid droplet proteins and metabolic diseases

Lipid droplets (LDs) are ubiquitous cellular organelles for lipid storage which are composed of a neutral lipid core bounded by a protein decorated phospholipid monolayer. Although lipid storage is their most obvious function, LDs are far from inert as they participate in maintaining lipid homeostasis through lipid synthesis, metabolism, and transportation. Furthermore, they are involved in cell signaling and other molecular events closely associated with human disease such as dyslipidemia, obesity, lipodystrophy, diabetes, fatty liver, atherosclerosis, and others. The last decade has seen a great increase in the attention paid to LD biology. Regardless, many fundamental features of LD biology remain obscure. In this review, we will discuss key aspects of LD biology including their biogenesis, growth and regression. We will also summarize the current knowledge about the role LDs play in human disease, especially from the perspective of the dynamics of the associated proteins. This article is part of a Special issue entitled Cardiac adaptations to obesity, diabetes and insulin resistance, edited by Professors Jan F.C. Glatz, Jason R.B. Dyck and Christine Des Rosiers.     

HopAZ1, a type III effector of Pseudomonas amygdali pv. tabaci,induces a hypersensitive response in tobacco wildfire-resistant Nicotiana tabacum ‘N509’

Pseudomonas amygdali pv. tabaci (formerly Pseudomonas syringae pv. tabaci; Pta) is a gram-negative bacterium that causes bacterial wildfire disease in Nicotiana tabacum. The pathogen establishes infections by using a type III secretion system to inject type III effector proteins (T3Es) into cells, thereby interfering with the host__s immune system. To counteract the effectors, plants have evolved disease-resistance genes and mechanisms to induce strong resistance on effector recognition. By screening a series of Pta T3E-deficient mutants, we have identified HopAZ1 as the T3E that induces disease resistance in N. tabacum ‘N509’. Inoculation with the Pta ∆hopAZ1 mutant did not induce resistance to Pta in N509. We also found that the Pta ∆hopAZ1 mutant did not induce a hypersensitive response and promoted severe disease symptoms in N509. Furthermore, a C-terminal truncated HopAZ1 abolished HopAZ1-dependent cell death in N509. These results indicate that HopAZ1 is the avirulence factor that induces resistance to Pta by N509.     

小鼠Cidea蛋白N端缺失异构体的鉴定和研究

Cidea蛋白调节脂肪代谢,在机体能量平衡过程中起重要作用,在转录和翻译后水平受到严格调控,但在翻译水平的调节还不清楚．通过对CIDEA基因敲除小鼠模型研究,鉴定了小鼠棕色脂肪组织内源性表达Cidea蛋白N端缺失异构体mCidea-22．定点突变等研究表明其产生机制为选择性起始翻译．并且,在异位表达时,N端缺失异构体和全长异构体的比例呈现细胞系特异性．此外,蛋白质稳定性实验表明mCidea-22半衰期很短．亚细胞定位研究显示mCidea-22是内质网和脂滴定位蛋白．为深入理解Cidea蛋白的功能和精细调节提供了新的思路和方向．     

鼠伤寒沙门菌入侵宿主细胞机制研究进展*

鼠伤寒沙门菌(Salmonella typhimurium)是一种人畜共患的肠道病原菌,可引起肠道炎症。该病原菌主要通过其致病岛(SPIs)编码的III型分泌系统(T3SS)分泌效应因子,包括促炎因子和抗炎因子。其在入侵肠上皮细胞时会释放促炎因子引发炎症反应,同时,为防止促炎因子过度破坏宿主细胞影响菌体的生存和繁殖,鼠伤寒沙门菌会产生一系列抗炎因子来调节细胞内信号通路,与宿主共同繁殖并最终全身扩散造成严重感染。旨在对鼠伤寒沙门菌利用T3SS效应因子入侵并调节宿主细胞信号通路机制进行概述。     

稻瘟菌无毒基因研究进展

稻瘟菌是引起水稻稻瘟病的病原物。水稻与稻瘟菌间存在广泛而特异的相互作用,是研究寄主与病原物互作的重要模式系统。本文对稻瘟菌与水稻互作最重要的激发子―无毒基因的研究现状进行了概括,讨论了无毒基因的定位、克隆方法以及已克隆无毒基因的功能及进化研究,同时对今后无毒基因研究的重要方向进行了探讨,为深入理解无毒基因的功能及与水稻可能的互作关系奠定了基础。     

温度、pH及效应剂对高粱PEP羧化酶活性的协同作用

纯化的高粱PEP羧化酶活性随pH升高(pH6.6～8.0)而增大。在G6P和Mal存在下,酶活性仍有随pH升高而增大的趋势,但G6P对酶的激活百分率和Mal的抑制百分率随pH升高而降低。高粱PEP羧化酶活性的最适温度高于40℃、酶的催化效率(V_(max)/K_m)随温度升高而增大。高温下,反应激活能降低,Mal对酶活性抑制百分率亦随温度升高而下降,I_(0.5)值增大,Mal增大K_m(PEP)的效应变小。